Carerx Corporation · TSX:CRRX
Carerx — Investor Presentation (December 2024)
17 slides from Carerx's investor presentation, December 2024
Slide 1: Investor Presentation December 2024
INVESTOR PRESENTATION December 2024 TSX: CRRX
Slide 2: Forward Looking Statements
Forward Looking Statements Certain of the statements contained in this presentation are "forward looking information within the meaning of applicable Canadian securities legislation. Forward looking information includes, but is not limited to, business strategy, plans and other expectations, beliefs
Slide 3: Canada's leading provider of specialty pharmacy services to seniors housing communities
Canada’s leading provider of specialty pharmacy services to seniors housing communities Enhancing the health of seniors with complex medication needs with high-touch, same-day delivery of specially packaged medications 3 3
Slide 4: Canadian Market
Canadian Market 1 in 5 Typical Seniors in Adults 65+ consume Canadians long-term care take ~40% are aged 4 to 12 of prescription drugs & medications daily ~25% 65 or older of OTC drugs Source: Statistics Canada 4 4 An aging population is driving unprecedented demand for medications and care services
Slide 5: Operational and Financial Highlights
Operational and Financial Highlights Nationwide ~89,000 ~1,450 Footprint Beds serviced Seniors housing communities served 26 5+ Fulfillment Year average contract CareRx centres term with our largest Tripled customers Bed count in ~89,000 3 years $92.8M $7.8M 8.4% 2024 Q3 2024 Q3 2024 Q3 2024 Revenue
Slide 6: Comprehensive Services Offering
Comprehensive Services Offering Servicing Seniors Service Seniors Living Pharmacists Distribution Facilities Living Facilities Onsite geriatric-certified clinical A leading distributor of medical Automated dispensing cabinets pharmacists + pharmacist-led supplies and continence and medication incide
Slide 7: Investment Highlights
Investment Highlights 1 2 3 4 Differentiated Contracted Increasing Infrastructure & Strategy Recurring Revenue Demand Technology Largest pure-play 5+ year contract length Increasing seniors National platform with pharmacy focused on with largest customers population and best-in-class technology long
Slide 8: Differentiated Strategy
Differentiated Strategy Retail Facility move-in consultation and specialized geriatric visits ✓ Deprescribing and routine medication reviews for safety & health ✓ ? 24/7 emergency medications and availability ✓ Free caregiver education and daily delivery ✓ ? Reduced errors with specialized packa
Slide 9: Contracted Recurring Revenue
Contracted Recurring Revenue • 5+ year contract length with largest customers funded by government payors • Capitated fee (fee/bed/month or fee-for-service) model for medications dispensed and clinical services Government Insurance • Payments billed directly to government and insurance • Non-covered
Slide 10: Increasing Demand
Increasing Demand Currently >500,000 1,025,000 CareRx congregate care beds 89,000 beds in Canada1 18% + Canada’s over 65 population is projected to grow by 2.7 million Current market has The Ontario over the next 5 years ~500,000 beds1 government has pledged to build Spending on senior care expected
Slide 11: Infrastructure & Technology
Infrastructure & Technology PacMed BD Rowa Key Technologies Supported by LTC Pharmacies Dose • Unit dose “pouch” packaged medications (PacMed and BD Rowa Dose) • eMAR software • Automated dispensing cabinets (ADCs) • Digital prescribing technologies (CPOE) • Medication incident management systems Te
Slide 12: Growth Strategy
Growth Strategy Organic Bed Wins • Broadening scope of products and services (e.g. Revicare, BOOMR., etc.) • Leverage scale & capabilities to provide superior pharmacy services offering • Increased focus on expansion to other congregate care settings • LTC occupancy increasing post-Covid Existing Pa
Slide 13: Financial Performance
Financial Performance Revenue Adj. EBITDA Operating Cash Flow $32.3 $27.4 $381.7 $370.7 $28.7 $22.3 $22.9 $262.6 $162.2 $12.8 $7.3 $0.02 FY '20 FY '21 FY '22 FY '23 FY '20 FY '21 FY '22 FY '23 FY '20 FY '21 FY '22 FY '23 Note: All figures in millions. 13 13 Organic growth and acquisitions driving ca
Slide 14: Margin Expansion
Margin Expansion Adj. EBITDA & Margin $8.0 $7.8 8.5% $7.5 $7.4 $7.5 $7.5 8.4% 8.3% $7.3 $7.0 8.2% 8.3% 8.2% 8.1% $6.5 7.9% $6.0 7.8% 7.7% $5.5 7.5% $5.0 7.3% Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Note: All figures in millions, unless specified. 14 14 Focused on revenue growth and margin expansion
Slide 15: Experienced Leadership Team
Experienced Leadership Team Puneet Khanna President & Chief Executive Officer Travis Featherstone Former Chief Commercial Officer, COO and SVP, Corporate Development of SVP, Western Operations & System Integration CareRx; former CEO of MED e-care Healthcare Solutions; former VP, Strategy & New Busin
Slide 16: Capitalization
Capitalization At November 29, 2024 Ownership Common Stock Ownership Shares Outstanding 62.2M Yorkville Asset Management 16,301,305 26.2% Share Price1 C$1.89 Directors & Officers 6,557,056 10.5% Market Cap C$117.5M Polar Asset Management 10,095,107 16.2% Cash $5.8M Other 29,229,122 47.0% Debt $47.7M
Slide 17: The Future of Senior Care
i, eeCarekx rerx.ca a) dlc) THE FUTURE OF SENIOR CARE